Survival outcome and prognostic factors for early-onset and late-onset metastatic colorectal cancer: a population based study from SEER database
- PMID: 38388566
- PMCID: PMC10883940
- DOI: 10.1038/s41598-024-54972-3
Survival outcome and prognostic factors for early-onset and late-onset metastatic colorectal cancer: a population based study from SEER database
Abstract
Colorectal cancer is the third most common cancer worldwide and there has been a concerning increase in the incidence rate of colorectal cancer among individuals under the age of 50. This study compared the survival outcome between early-onset and late-onset metastatic colorectal cancer to find the differences and identify their prognostic factors. We obtained patient data from SEER database. Survival outcome was estimated using Kaplan-Meier survival curves and compared using the log-rank test. Univariate and multivariate analyses were conducted utilizing COX models to identify their independent prognostic factors. A total of 10,036 early-onset metastatic colorectal (EOCRC) cancer patients and 56,225 late-onset metastatic colorectal cancer (LOCRC) patients between 2010 and 2019 were included in this study. EOCRC has more survival benefits than LOCRC. Tumor primary location (p < 0.001), the location of metastasis (p < 0.001) and treatment modalities (p < 0.001) affect the survival outcomes between these two groups of patients. Female patients had better survival outcomes in EOCRC group (p < 0.001), but no difference was found in LOCRC group (p = 0.57). In conclusion, our study demonstrated that EOCRC patients have longer survival time than LOCRC patients. The sex differences in survival of metastatic colorectal cancer patients are associated with patients' age. These findings contribute to a better understanding of the differences between metastatic EOCRC and LOCRC, and can help inform the development of more precise treatment guidelines to improve prognosis.
Keywords: Early-onset colorectal cancer; Metastatic cancer; Survival.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures







Similar articles
-
Development and validation of survival prediction tools in early and late onset colorectal cancer patients.Sci Rep. 2025 Apr 15;15(1):12864. doi: 10.1038/s41598-025-95385-0. Sci Rep. 2025. PMID: 40229310 Free PMC article.
-
Five-year overall survival of early- and late-onset colorectal cancer in Medellín, Colombia: a comparative study.J Cancer Res Clin Oncol. 2024 Nov 9;150(11):490. doi: 10.1007/s00432-024-06007-7. J Cancer Res Clin Oncol. 2024. PMID: 39516395 Free PMC article.
-
Trends, clinicopathological features, surgical treatment patterns and prognoses of early-onset versus late-onset colorectal cancer: A retrospective cohort study on 34067 patients managed from 2000 to 2021 in a Chinese tertiary center.Int J Surg. 2022 Aug;104:106780. doi: 10.1016/j.ijsu.2022.106780. Epub 2022 Jul 16. Int J Surg. 2022. PMID: 35850466
-
Early-onset colorectal cancer: why it should be high on our list of differentials.ANZ J Surg. 2022 Jul;92(7-8):1638-1643. doi: 10.1111/ans.17698. Epub 2022 Apr 21. ANZ J Surg. 2022. PMID: 35451218 Free PMC article. Review.
-
Gut Microbiota Profiles in Early- and Late-Onset Colorectal Cancer: A Potential Diagnostic Biomarker in the Future.Digestion. 2021;102(6):823-832. doi: 10.1159/000516689. Epub 2021 Aug 25. Digestion. 2021. PMID: 34433172 Review.
Cited by
-
Young-onset metastatic colorectal cancer: an opportunity and a vision for progress in cancer.Med Oncol. 2025 Mar 8;42(4):95. doi: 10.1007/s12032-025-02640-5. Med Oncol. 2025. PMID: 40056288 Free PMC article. Review.
-
Differential Analysis of Early-Onset and Late-Onset Colorectal Cancer Based on Multidimensional Evidence Integration: A Review.Cancer Control. 2025 Jan-Dec;32:10732748251363337. doi: 10.1177/10732748251363337. Epub 2025 Jul 30. Cancer Control. 2025. PMID: 40736365 Free PMC article. Review.
-
Early Onset Colorectal Cancer: Molecular Underpinnings Accelerating Occurrence.Cell Mol Gastroenterol Hepatol. 2025;19(2):101425. doi: 10.1016/j.jcmgh.2024.101425. Epub 2024 Nov 5. Cell Mol Gastroenterol Hepatol. 2025. PMID: 39510499 Free PMC article. Review.
-
Peripheral myelin protein 2 is underexpressed in early-onset colorectal cancer and inhibits metastasis.Front Mol Biosci. 2025 Jun 5;12:1610003. doi: 10.3389/fmolb.2025.1610003. eCollection 2025. Front Mol Biosci. 2025. PMID: 40538623 Free PMC article.
-
Early-Onset Colorectal Adenocarcinoma and Multiple Metastases in an 11-Year-Old Patient With KRAS Mutation: A Case Report.Cureus. 2025 Mar 26;17(3):e81235. doi: 10.7759/cureus.81235. eCollection 2025 Mar. Cureus. 2025. PMID: 40291278 Free PMC article.
References
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical